Close
May 24, 2024 10:39AM
May 24, 2024 09:30AM
May 24, 2024 08:37AM
May 24, 2024 08:22AM
May 24, 2024 08:20AM
May 24, 2024 07:38AM
May 24, 2024 07:30AM BridgeBio Pharma (BBIO) to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis
May 24, 2024 07:00AM
May 24, 2024 07:00AM
May 24, 2024 06:53AM
May 24, 2024 06:01AM
May 24, 2024 05:49AM
May 24, 2024 05:49AM
May 23, 2024 05:11PM Sensei Biotherapeutics (SNSE) Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
May 23, 2024 05:02PM
May 23, 2024 05:02PM
May 23, 2024 05:00PM
May 23, 2024 04:06PM
May 23, 2024 02:45PM
May 23, 2024 08:15AM
May 23, 2024 07:31AM Natera (NTRA) to Present New MRD Data in Multiple Tumor Types
May 23, 2024 07:05AM
May 23, 2024 07:00AM
May 22, 2024 04:55PM
May 22, 2024 09:03AM
May 22, 2024 08:15AM
May 22, 2024 08:05AM
May 22, 2024 08:02AM BioVie Inc. (BIVI) Bezisterim Demonstrates Potential Improvements in Sleep/Fatigue and Restless Leg Symptoms for Parkinson’s Disease Patients
May 22, 2024 08:01AM
May 22, 2024 07:37AM
May 22, 2024 07:05AM
May 22, 2024 07:02AM
May 22, 2024 07:01AM
May 21, 2024 05:00PM
May 21, 2024 04:07PM Rezolute Inc. (RZLT) Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402
May 21, 2024 02:30PM
May 21, 2024 09:27AM
May 21, 2024 08:45AM
May 21, 2024 08:45AM
May 21, 2024 08:35AM
May 21, 2024 08:30AM
May 21, 2024 08:30AM Palisade Bio Inc. (PALI) Reports PALI-2108 Demonstrated Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models
May 21, 2024 08:06AM
May 21, 2024 08:04AM
May 21, 2024 08:02AM
May 21, 2024 08:01AM
May 21, 2024 08:01AM
May 21, 2024 07:30AM
May 21, 2024 07:16AM Halozyme Therapeutics (HALO) Announces Bristol Myers Squibb (BMY) Received Updated Action Date from FDA for Subcutaneous Nivolumab Co-Formulated with ENHANZE
May 21, 2024 07:15AM

67,154 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving FDA reports.